ProfileGDS4459 / ENSG00000179954
TitleIntraportal tacrolimus flushing effect on liver allograft
OrganismHomo sapiens


flushed with tacrolimus flushed with albumin control GSM623464 GSM623465 GSM623466 GSM623467 GSM623468 GSM623469 GSM623470 GSM623471 GSM623472 GSM623473 GSM623474 GSM623475 GSM623476 GSM623477 GSM623478 GSM623479 GSM623480 76% 79% 68% 83% 72% 71% 72% 67% 67% 71% 68% 68% 73% 75% 67% 75% 56% sort by protocol Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM623464group A, liver allograft wedge biopsie tacrolimus treatment 15.6476
GSM623465group A, liver allograft wedge biopsie tacrolimus treatment 25.8279
GSM623466group A, liver allograft wedge biopsie tacrolimus treatment 35.2468
GSM623467group A, liver allograft wedge biopsie tacrolimus treatment 46.0783
GSM623468group A, liver allograft wedge biopsie tacrolimus treatment 55.4472
GSM623469group A, liver allograft wedge biopsie tacrolimus treatment 65.3571
GSM623470group A, liver allograft wedge biopsie tacrolimus treatment 75.5872
GSM623471group A, liver allograft wedge biopsie tacrolimus treatment 85.1567
GSM623472group A, liver allograft wedge biopsie tacrolimus treatment 95.1967
GSM623473group A, liver allograft wedge biopsie tacrolimus treatment 105.4371
GSM623474group B, liver allograft wedge biopsie placebo treatment 15.168
GSM623475group B, liver allograft wedge biopsie placebo treatment 25.2868
GSM623476group B, liver allograft wedge biopsie placebo treatment 35.5773
GSM623477group B, liver allograft wedge biopsie placebo treatment 45.4875
GSM623478group B, liver allograft wedge biopsie placebo treatment 55.1967
GSM623479group B, liver allograft wedge biopsie placebo treatment 65.575
GSM623480group B, liver allograft wedge biopsie placebo treatment 74.5956